$0.1518
-0.0098-6.06%
Dern. MÀJ: Oct 26, 6:56 PM
Arcadia Biosciences (RKDA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Q2 (2023) a publié ses dernières prévisions le $1.3M - $1.5M pour Arcadia Biosciences {{epsDirection}}. La société a prévu un chiffre d'affaires compris entre {{epsPriorRange}} et {{revenueDirection}} pour la période.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-0.80 | $-0.66 | $-0.54 |
| Actual | $-2.09 | $-2.11 | $-0.97 | $0.63 |
| Surprise | — | -163.8% | -47.0% | +216.7% |
| Revenue | ||||
| Estimate | — | $1.6M | $1.4M | $1.9M |
| Actual | $1.4M | $1.1M | $901000 | $1.3M |
| Surprise | — | -31.3% | -35.6% | -31.5% |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $-2.11 | $-0.80 | -163.8 % |
| Q4 | Mar 26, 2026 | $-0.97 | $-0.66 | -47.0 % |
| Q3 | Nov 7, 2025 | $0.63 | $-0.54 | 216.7 % |
| Q1 | May 8, 2025 | $1.90 | $-0.37 | 613.5 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $1.10M | $1.60M | -31.3 % |
| Q4 | Mar 26, 2026 | $901.00K | $1.40M | -35.6 % |
| Q3 | Nov 7, 2025 | $1.30M | $1.90M | -31.5 % |
| Q2 | Aug 14, 2025 | $1.46M | $1.60M | -9.06 % |